You are here

Article Text

Article menu
Download PDFPDF
Adult nursing
Systematic review with meta analysis
Taking aspirin daily for at least 4 years reduces long-term risk of cancer death
  1. Elizabeth Ann Coleman
  1. College of Nursing, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
  1. Correspondence to Elizabeth Ann Coleman
    Mail Slot 529, 4301 West Markham Street, Little Rock, AR 72205, USA; colemanann{at}uams.edu

http://dx.doi.org/10.1136/ebn1165

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Rothwell PM, Fowkes FG, Belch JF, et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011;377:31–41.OpenUrlCrossRefPubMedWeb of Science

    Implications for practice and research

    • ▪ The study findings that daily aspirin reduced cancer death by 20% need to be factored into guideline recommendations. The large effect size of aspirin, even in low dose, in preventing cancer may outweigh the small risk of stomach bleeds.

    • ▪ It may be recommended that persons at age 40 take daily low-dose aspirin to prevent cancer, not just of adenocarinoma of the gastrointestinal tract but of adenocarinoma of other tumour sites.

    • ▪ More trial data are needed on cancers that affect women, especially breast and gynaecological cancers.

    Context

    Cancer …

    View Full Text

    Footnotes

    • Competing interests None.